Target Group, Inc. (Canada) (CBDY)
0.0007
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Target Group EPS Diluted (Quarterly) : -0.0004 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0004 |
| March 31, 2026 | -0.0009 |
| December 31, 2025 | -0.0009 |
| September 30, 2025 | -0.0008 |
| June 30, 2025 | -0.0004 |
| March 31, 2025 | -0.0002 |
| December 31, 2024 | 0.0004 |
| September 30, 2024 | -0.0009 |
| June 30, 2024 | 0.0011 |
| March 31, 2024 | -0.0003 |
| December 31, 2023 | -0.0003 |
| September 30, 2023 | -0.0006 |
| June 30, 2023 | 0.0013 |
| March 31, 2023 | -0.0012 |
| December 31, 2022 | -0.0064 |
| September 30, 2022 | -0.0005 |
| June 30, 2022 | 0.0003 |
| March 31, 2022 | -0.0009 |
| December 31, 2021 | -0.0001 |
| September 30, 2021 | 0.0036 |
| June 30, 2021 | 0.0014 |
| March 31, 2021 | -0.0047 |
| December 31, 2020 | -0.0094 |
| September 30, 2020 | -0.0069 |
| June 30, 2020 | -0.0011 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.005 |
| December 31, 2019 | -0.0106 |
| September 30, 2019 | -0.0018 |
| June 30, 2019 | -0.0054 |
| March 31, 2019 | -0.0106 |
| December 31, 2018 | 0.0059 |
| September 30, 2018 | -0.0363 |
| June 30, 2018 | -0.03 |
| March 31, 2018 | 0.004 |
| December 31, 2017 | -0.0458 |
| September 30, 2017 | -0.29 |
| June 30, 2017 | -210.00 |
| March 31, 2017 | -11.00 |
| December 31, 2016 | -2.64 |
| September 30, 2016 | -50.00 |
| June 30, 2016 | -10.00 |
| March 31, 2016 | -20.00 |
| December 31, 2015 | -280.00 |
| September 30, 2015 | -30.00 |
| June 30, 2015 | -20.00 |
| March 31, 2015 | -15.91 |
| December 31, 2014 | -34.81 |
| September 30, 2014 | -17.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.11 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lexaria Bioscience Corp. | -1.204 |
| InMed Pharmaceuticals, Inc. | -1.434 |
| XORTX Therapeutics, Inc. | -1.045 |
| NervGen Pharma Corp. | -0.2283 |
| Milestone Pharmaceuticals, Inc. | -0.2063 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.2398M |
| Revenue (Quarterly) | 1.371M |
| Total Expenses (Quarterly) | 1.611M |
| Enterprise Value | 11.59M |
| Gross Profit Margin (Quarterly) | 28.44% |
| Profit Margin (Quarterly) | -17.49% |
| Earnings Yield | -428.6% |
| Normalized Earnings Yield | -414.29 |